Sara A. Hunter

Sara A. Hunter

Auto-generated profile, based on publicly available information

Sara A. Hunter

Cleveland Clin, Imaging Inst, Radiol, Cleveland, OH USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
SHSara A. Hunter
Sara A. Hunter
KBKavita Bhatt
Kavita Bhatt

1 January 2020 in RadioGraphics
Verified
Journal Article
Closed access
MFMyra K. Feldman
Myra K. Feldman
SHSara A. Hunter
Sara A. Hunter
UPUma C. Perni
Uma C. Perni
PLPeter Liu
Peter Liu
CQCristiano Quintini
Cristiano Quintini
RFRebecca Flyckt
Rebecca Flyckt
Uterine transplantation is a new treatment option for patients with absolute uterine factor infertility, and imaging is essential for preoperative planning and postoperative assessment. Uterine transplantation (UT) is a novel treatment for absolute uterine factor infertility (AUFI) that is currently being performed under experimental protocols in multiple medical centers worldwide...

15 June 2022 in Cancer Research
Verified
Journal Article
Open access
MPManishkumar S. Patel
Manishkumar S. Patel
AJAkansha Jalota
Akansha Jalota
AMAgrima Mian
Agrima Mian
PBPeter Bazeley
Peter Bazeley
SHSara A. Hunter
Sara A. Hunter
NGNeetu Gupta
Neetu Gupta
Introduction: Despite the exceptional promise of anti-CD19 CAR T-cell therapy, 40-60% of relapsed or refractory large B-cell lymphoma (R/R LBCL) patients exhibit poor response and survival. Therefore, identification of pre-treatment markers of response to anti-CD19 CAR T-cell therapy is essential. Immune responses to infections and many autoimmune diseases exhibit gender bias, but it is not known if gender influences response to CAR T-cell therapy. We performed serum profiling to identify pre-treatment cytokines and chemokines associated with response and survival in male and female LBCL patients treated with axicabtagene ciloleucel (axi-cel). Methods: Serum samples were collected from peripheral blood at the time of leukapheresis from 42 R/R LBCL patients treated with axi-cel. Multiplexed bead arrays were used to quantify baseline levels of 51 serum cytokines, chemokines and cytotoxic proteins. Unpaired Wilcoxon test was used to analyze the association of baseline cytokine levels with 3-month response, and Kaplan-Meier survival analysis for association with survival outcomes. Statistical analyses were performed using R and p<0.05 was considered significant. Results: The median age of patients was 61 y, and 62% of the patients were male. All patients had been previously treated with R-CHOP or R-EPOCH, and had a median of 3 prior lines of therapy, including 47.6% with autologous stem cell transplantation. Male non-responders (stable/progressive disease) had significantly higher baseline levels of IL-6, IL-8, IL-1RA, MIP-1α, GM-CSF and CRP compared to responders (complete/partial response). Higher levels of IL-6, IL-8, IL-27, and CRP were significantly associated with poor overall survival (OS), and IL-6, IL-8, MIP-1β, and CRP with poor progression-free survival (PFS) in male patients. Baseline metabolic tumor volume (MTV) and lactate dehydrogenase (LDH) levels were also significantly higher in male patients with poor OS and PFS. Finally, baseline IL-8 and CRP were significantly associated with baseline MTV and LDH levels in male patients. Conclusions: Our data show that pre-treatment proinflammatory proteins IL-8, IL-6, CRP are associated with poor response and survival in axi-cel-treated male but not female LBCL patients. The correlation of high levels of these factors with high pretreatment tumor burden in male non-responder R/R LBCL patients is suggestive of an immunosuppressive tumor microenvironment that is unlikely to support optimal expansion of anti-CD19 CAR T cells, resulting in poor response and survival outcomes. Citation Format: Manishkumar S. Patel, Akansha Jalota, Agrima Mian, Peter Bazeley, Sara A. Hunter, Brian T. Hill, Neetu Gupta. Gender bias in the association of pre-treatment cytokine signatures with response and survival in B cell lymphoma patients treated with anti-CD19 CAR T-cell therapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1262.

26 March 2024 in Journal of the American College of Radiology
Verified
Journal Article
Open access
SHSara A. Hunter
Sara A. Hunter
JBJennifer Bullen
Jennifer Bullen
KHKyle J. Hunter
Kyle J. Hunter
KBKavita Bhatt
Kavita Bhatt
Objective: The purpose of this investigation was to assess gaps in radiologists' ' medical knowledge using abdominal subspecialty online longitudinal assessment (OLA)-type questions. Secondarily, we evaluated what question-centric factors influenced fl uenced radiologists to pursue self-directed additional reading on topics presented. Methods: A prospective OLA-type test was distributed nationally to radiologists over a 4-month period. Questions were divided into multiple groupings, including arising from three different time periods of literature (<= 5 years, 6-15 years, and > 20 years), relating to common versus uncommon modalities, and guideline-based versus knowledge-based characterization. After each question, participants rated their confidence fi dence in diagnosis and perceived question relevance. Answers were provided, and links to answer explanations and references were provided and tracked. A series of regression models were used to test potential predictors of correct response, participant confidence, fi dence, and perceived question relevance. Results: In all, 119 participants initiated the survey, with 100 answering at least one of the questions. Participants had significantly fi cantly lower perceived relevance (mean: 51.3, 59.2, and 62.1 for topics <= 5 years old, 6-15 years old, and > 20 years old, respectively; P < .001) and confidence fi dence (mean: 48.4, 57.8, and 63.4, respectively; P < .001) with questions on newer literature compared with older literature. Participants were significantly fi cantly more likely to read question explanations for questions on common modalities compared with uncommon (46% versus 40%; P = .005) and on guideline-based questions compared with knowledge-based questions (49% versus 43%; P = .01). Discussion: OLA-type questions function by identifying areas in which radiologists lack knowledge or confidence fi dence and highlight areas in which participants have interest in further education.